Hualan Biological Engineering Inc
SZSE:002007

Watchlist Manager
Hualan Biological Engineering Inc Logo
Hualan Biological Engineering Inc
SZSE:002007
Watchlist
Price: 16.48 CNY 0.18% Market Closed
Market Cap: 30.1B CNY
Have any thoughts about
Hualan Biological Engineering Inc?
Write Note

Hualan Biological Engineering Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hualan Biological Engineering Inc
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Hualan Biological Engineering Inc
SZSE:002007
Interest Income Expense
ÂĄ191.8m
CAGR 3-Years
8%
CAGR 5-Years
5%
CAGR 10-Years
10%
Beigene Ltd
HKEX:6160
Interest Income Expense
-ÂĄ59.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Interest Income Expense
-ÂĄ106.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Interest Income Expense
ÂĄ217.7m
CAGR 3-Years
N/A
CAGR 5-Years
134%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Interest Income Expense
-ÂĄ8.1m
CAGR 3-Years
N/A
CAGR 5-Years
58%
CAGR 10-Years
9%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Interest Income Expense
-ÂĄ66.3m
CAGR 3-Years
-3%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
No Stocks Found

Hualan Biological Engineering Inc
Glance View

Market Cap
30.1B CNY
Industry
Biotechnology

Hualan Biological Engineering, Inc. engages in the research and development, production, and sale of biological products. The company is headquartered in Xinxiang, Henan and currently employs 2,927 full-time employees. The company went IPO on 2004-06-25. The company also produces vaccine products and biological engineering products. The firm's main products include human albumins, human immunoglobulin for intravenous injection, human immunoglobulin, human coagulation factors, human rabies immunoglobulin, human tetanus immunoglobulin and influenza vaccines, among others. The firm mainly operates its businesses in domestic markets.

Intrinsic Value
26.95 CNY
Undervaluation 39%
Intrinsic Value
Price

See Also

What is Hualan Biological Engineering Inc's Interest Income Expense?
Interest Income Expense
191.8m CNY

Based on the financial report for Sep 30, 2024, Hualan Biological Engineering Inc's Interest Income Expense amounts to 191.8m CNY.

What is Hualan Biological Engineering Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
10%

Over the last year, the Interest Income Expense growth was -4%. The average annual Interest Income Expense growth rates for Hualan Biological Engineering Inc have been 8% over the past three years , 5% over the past five years , and 10% over the past ten years .

Back to Top